Mike Lind

Professor Michael Lind

Foundation Professor of Oncology/ Head of the Joint Centre for Cancer Studies

Faculty and Department

  • Faculty of Health Sciences
  • Hull York Medical School

Summary

Professor Michael Lind has been involved in medical oncology for the last 35 years, 25 years as aconsultant. His major research interests are in Lung Cancer amd mesothelioma. He chairs the National Cancer Registration and Analysis Service lung group for Public Health England. Developing cancer services in East Yorkshire, oncogeriatrics and translational research.

Journal Article

CAMERA - complete assessment of elderly patients with cancer: A non-randomised feasibility study

Jackson, G., Gabe, R., Johnson, M., Date, K., Harman, D., Maraveyas, A., …Lind, M. J. (2019). CAMERA - complete assessment of elderly patients with cancer: A non-randomised feasibility study. Journal of Geriatric Oncology, 10(1), 175-177. doi:10.1016/j.jgo.2018.07.005

MicroRNA-31 regulates chemosensitivity in malignant pleural mesothelioma

Moody, H. L., Lind, M. J., & Maher, S. G. (2017). MicroRNA-31 regulates chemosensitivity in malignant pleural mesothelioma. Molecular Therapy - Nucleic Acids, 8(15 September 2017), 317-329. https://doi.org/10.1016/j.omtn.2017.07.001

Arginine deprivation with pegylated Arginine Deiminase in patients with Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial

Szlosarek, P. W., Steele, J. P., Nolan, L., Gilligan, D., Taylor, P., Spicer, J., …Hackshaw, A. (2017). Arginine deprivation with pegylated Arginine Deiminase in patients with Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial. JAMA Oncology, 3(1), 58-66. doi:10.1001/jamaoncol.2016.3049

The effect of emergency presentation on surgery and survival in lung cancer patients in England, 2006–2008

Tataru, D., Jack, R. H., Lind, M. J., Møller, H., & Lüchtenborg, M. (2015). The effect of emergency presentation on surgery and survival in lung cancer patients in England, 2006–2008. Cancer epidemiology, 39(4), (612-616). doi:10.1016/j.canep.2015.04.008. ISSN 1877-7821

Clinical response to primary letrozole therapy in elderly patients with early breast cancer : possible role for p53 as a biomarker

Garimella, V., Hussain, T., Agarwal, V., Radhakrishna, S., Fox, J. N., Kneeshaw, P. J., …Cawkwell, L. (2014). Clinical response to primary letrozole therapy in elderly patients with early breast cancer : possible role for p53 as a biomarker. International journal of surgery, 12(8), 821-826. https://doi.org/10.1016/j.ijsu.2014.06.009

Postgraduate supervision

Lung and breast cancer, oncogeriatrics, mesothelioma Completed PhDs 10 PhDs2 MDs Current PhD Supervisor 1 PhD1 MD